Management of Acinetobacter Infections in the Immunosuppressed Host

Emily Baneman; Meenakshi M. Rana

doi:10.1007/978-3-030-25869-6_16

Management of Acinetobacter Infections in the Immunosuppressed Host

Emily Baneman
, Meenakshi M. Rana

Research output: Chapter in Book/Report/Conference proceeding › Chapter › peer-review

1 Scopus citations

Abstract

Acinetobacter infections have emerged as an important pathogen in transplant recipients. It is a major cause of multidrug-resistant nosocomial infections, particularly pneumonia and bloodstream infections, and is associated with high morbidity and mortality. Given the organism’s propensity to develop resistance to multiple classes of antibiotics, treatment options can be limited but frequently include carbapenems, polymyxins, sulbactams, tetracyclines, and glycylcyclines. Infection prevention measures are critical for preventing transmission among patients and avoiding hospital outbreaks.

Original language	English
Title of host publication	Emerging Transplant Infections
Subtitle of host publication	Clinical Challenges and Implications
Publisher	Springer International Publishing
Pages	371-389
Number of pages	19
ISBN (Electronic)	9783030258696
ISBN (Print)	9783030258689
DOIs	https://doi.org/10.1007/978-3-030-25869-6_16
State	Published - 1 Jan 2021

Keywords

Acinetobacter
Carbapenems
Multidrug resistant infection
Nosocomial infection
Polymyxins
Ventilator-associated pneumonia

Access to Document

10.1007/978-3-030-25869-6_16

Cite this

@inbook{b9390216af5341eeabf62c053bb5b400,

title = "Management of Acinetobacter Infections in the Immunosuppressed Host",

abstract = "Acinetobacter infections have emerged as an important pathogen in transplant recipients. It is a major cause of multidrug-resistant nosocomial infections, particularly pneumonia and bloodstream infections, and is associated with high morbidity and mortality. Given the organism{\textquoteright}s propensity to develop resistance to multiple classes of antibiotics, treatment options can be limited but frequently include carbapenems, polymyxins, sulbactams, tetracyclines, and glycylcyclines. Infection prevention measures are critical for preventing transmission among patients and avoiding hospital outbreaks.",

keywords = "Acinetobacter, Carbapenems, Multidrug resistant infection, Nosocomial infection, Polymyxins, Ventilator-associated pneumonia",

author = "Emily Baneman and Rana, \{Meenakshi M.\}",

note = "Publisher Copyright: {\textcopyright} Springer Nature Switzerland AG 2021.",

year = "2021",

month = jan,

day = "1",

doi = "10.1007/978-3-030-25869-6\_16",

language = "English",

isbn = "9783030258689",

pages = "371--389",

booktitle = "Emerging Transplant Infections",

publisher = "Springer International Publishing",

}

TY - CHAP

T1 - Management of Acinetobacter Infections in the Immunosuppressed Host

AU - Baneman, Emily

AU - Rana, Meenakshi M.

N1 - Publisher Copyright: © Springer Nature Switzerland AG 2021.

PY - 2021/1/1

Y1 - 2021/1/1

N2 - Acinetobacter infections have emerged as an important pathogen in transplant recipients. It is a major cause of multidrug-resistant nosocomial infections, particularly pneumonia and bloodstream infections, and is associated with high morbidity and mortality. Given the organism’s propensity to develop resistance to multiple classes of antibiotics, treatment options can be limited but frequently include carbapenems, polymyxins, sulbactams, tetracyclines, and glycylcyclines. Infection prevention measures are critical for preventing transmission among patients and avoiding hospital outbreaks.

AB - Acinetobacter infections have emerged as an important pathogen in transplant recipients. It is a major cause of multidrug-resistant nosocomial infections, particularly pneumonia and bloodstream infections, and is associated with high morbidity and mortality. Given the organism’s propensity to develop resistance to multiple classes of antibiotics, treatment options can be limited but frequently include carbapenems, polymyxins, sulbactams, tetracyclines, and glycylcyclines. Infection prevention measures are critical for preventing transmission among patients and avoiding hospital outbreaks.

KW - Acinetobacter

KW - Carbapenems

KW - Multidrug resistant infection

KW - Nosocomial infection

KW - Polymyxins

KW - Ventilator-associated pneumonia

UR - https://www.scopus.com/pages/publications/85149592235

U2 - 10.1007/978-3-030-25869-6_16

DO - 10.1007/978-3-030-25869-6_16

M3 - Chapter

AN - SCOPUS:85149592235

SN - 9783030258689

SP - 371

EP - 389

BT - Emerging Transplant Infections

PB - Springer International Publishing

ER -

Management of Acinetobacter Infections in the Immunosuppressed Host

Abstract

Keywords

Access to Document

Fingerprint

Cite this